We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+13.01%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$234B
AUM Growth
+$27.2B
Cap. Flow
+$4.48B
Cap. Flow %
1.91%
Top 10 Hldgs %
17.69%
Holding
6,610
New
800
Increased
2,296
Reduced
2,513
Closed
633

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$1.19B
2
PLTR icon
Palantir
PLTR
+$742M
3
HES
Hess
HES
+$478M
4
ORCL icon
Oracle
ORCL
+$465M
5
TRI icon
Thomson Reuters
TRI
+$442M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Financials 7.68%
3 Healthcare 6.5%
4 Industrials 5.87%
5 Consumer Discretionary 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLYB icon
6276
Rallybio
RLYB
$89.4M
-22,480
Closed -$60.8K
RNW icon
6277
CALL
ReNew
RNW
$2.48B
-258,333
Closed -$1.39M
ROP icon
6278
CALL
Roper Technologies
ROP
$40.7B
-11,100
Closed -$6.29M
RPTX
6279
DELISTED
Repare Therapeutics
RPTX
-407,858
Closed -$567K
RR icon
6280
Richtech Robotics
RR
$380M
-26,643
Closed -$52K
RTO icon
6281
Rentokil
RTO
$11.9B
-28,746
Closed -$690K
RUM icon
6282
CALL
RUM Group Inc
RUM
$4.49B
-50,000
Closed -$449K
RXO icon
6283
RXO
RXO
$3.72B
-517,127
Closed -$8.13M
RXRX icon
6284
Recursion Pharmaceuticals
RXRX
$1.88B
-739,408
Closed -$3.74M
RYTM icon
6285
PUT
Rhythm Pharmaceuticals
RYTM
$7.57B
-10,000
Closed -$632K
SABA
6286
Saba Capital Income & Opportunities Fund II
SABA
$219M
-16,591
Closed -$152K
SACH
6287
Sachem Capital Corp
SACH
$39.6M
-14,367
Closed -$17.2K
SAGE
6288
CALL
DELISTED
Sage Therapeutics
SAGE
-154,500
Closed -$1.41M
SAGE
6289
DELISTED
Sage Therapeutics
SAGE
-1,002,709
Closed -$9.14M
SAIA icon
6290
CALL
Saia
SAIA
$9.66B
-20,000
Closed -$5.48M
SAIA icon
6291
Saia
SAIA
$9.66B
-128,886
Closed -$35.3M
SATX
6292
DELISTED
SatixFy Communications
SATX
-219,361
Closed -$643K
SB icon
6293
Safe Bulkers
SB
$869M
-76,856
Closed -$277K
SBCF icon
6294
Seacoast Banking Corp of Florida
SBCF
$3.35B
-15,291
Closed -$422K
SBGI icon
6295
Sinclair Inc
SBGI
$1.04B
-101,591
Closed -$1.4M
SBSW icon
6296
CALL
Sibanye-Stillwater
SBSW
$8.9B
-50,000
Closed -$361K
SFM icon
6297
CALL
Sprouts Farmers Market
SFM
$7.56B
-1,600
Closed -$263K
SGMT icon
6298
PUT
Sagimet Biosciences
SGMT
$637M
-87,800
Closed -$669K
SGOV icon
6299
iShares 0-3 Month Treasury Bond ETF
SGOV
$103B
-13,869
Closed -$1.4M
SGRY icon
6300
Surgery Partners
SGRY
$1.9B
-400,134
Closed -$8.89M

Similar funds

Israel Englander's Q3 2025 Portfolio in Review

As of Q3 2025, Israel Englander held 6,610 positions worth $234B, up 13% from $207B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Israel Englander's Q3 2025 filing shows 800 new, 2,296 increased, 2,513 reduced and 633 closed positions. Its largest new stake was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M. The largest sale was Applovin, an estimated $1.19B.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, up from 8.7% a quarter earlier, followed by Financials and Healthcare.

  • Israel Englander's largest Q3 2025 buy was Vanguard Long-Term Corporate Bond ETF: 1,212,092 shares worth $94.1M.
  • Israel Englander added most to NVIDIA in Q3 2025, an estimated $1.78B increase.
  • Israel Englander's biggest Q3 2025 reduction was Applovin, cutting an estimated $1.19B.
  • Israel Englander fully exited Hess in Q3 2025, selling an estimated $478M.
  • Israel Englander's ten largest holdings make up 18% of its $234B portfolio in Q3 2025.
  • Israel Englander opened 800 new positions and closed 633 in Q3 2025.
  • Israel Englander's portfolio value rose 13% quarter-over-quarter to $234B.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.